Area of research
Pulmonary and Respiratory Medicine · Genetics
Research interest
Research interests include Brain Metastases and Treatment, Glioma Diagnosis and Treatment, Management of metastatic bone disease, and Lung Cancer Research Studies.
Radiotherapy at the limits of age: evolving fractionation strategies, symptom palliation, and survival in nonagenarians
Ongoing prospective studies on reirradiation: A systematic review of a clinical trials database.
External Validation of an Extended Prognostic Assessment Model in Patients With Brain Metastases from Small‐cell Lung Cancer
Consequences of adverse events in cancer immunotherapy combinations - a comprehensive real-world analysis.
Patient-reported symptoms before adjuvant locoregional radiotherapy for breast cancer: triple-negative histology impacts the symptom burden.
PRO: Do We Still Need Whole-Brain Irradiation for Brain Metastases?
Prospective randomized clinical studies involving reirradiation: update of a systematic review.
Palliative appropriateness criteria: external validation of a new method to evaluate the suitability of palliative radiotherapy fractionation.
The LabPS score: Inexpensive, Fast, and Site-agnostic Survival Prediction.
European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus on re-irradiation: definition, reporting, and clinical decision making
30-day mortality in patients treated for brain metastases: extracranial causes dominate.
Primary systemic therapy for patients with brain metastases from lung cancer ineligible for targeted agents.
Feasibility and efficacy of early docetaxel plus androgen deprivation therapy for metastatic hormone-sensitive prostate cancer in a rural health care setting.
Palliative non-small cell lung cancer treatment and end-of-life care stratified by sex and childlessness: an important interplay in unmarried patients?
Hippocampus-Avoidance Whole-Brain Radiation Therapy Is Efficient in the Long-Term Preservation of Hippocampal Volume
New clinical data on human spinal cord re-irradiation tolerance.
Assessment of extracranial metastatic disease in patients with brain metastases: How much effort is needed in the context of evolving survival prediction models?
Hippocampus‐avoidance whole‐brain radiation therapy with a simultaneous integrated boost for multiple brain metastases
Radiotherapy for nonagenarians: the value of biological versus chronological age
Long-term survival results after treatment for oligometastatic brain disease
Long-term survival results after treatment for oligometastatic brain disease.
Risk factors for esophagitis after hypofractionated palliative (chemo) radiotherapy for non-small cell lung cancer.
Validation of the graded prognostic assessment for gastrointestinal cancers with brain metastases (GI-GPA)
Validation of the graded prognostic assessment for gastrointestinal cancers with brain metastases (GI-GPA).
Provider decision regret-a useful method for analysis of palliative thoracic re-irradiation for lung cancer?
Feasibility and efficacy of sequential systemic therapy for metastatic castration-resistant prostate cancer in a rural health care setting.
Risk factors for esophagitis after hypofractionated palliative (chemo)radiotherapy for non-small cell lung cancer
Is there a seasonal variation of survival after systemic chemotherapy for metastatic castration-resistant prostate cancer in a rural part of North Norway?
Risk factors for esophagitis after hypofractionated palliative (chemo)radiotherapy for non-small cell lung cancer
Management of patients with brain metastases from non-small cell lung cancer and adverse prognostic features: multi-national radiation treatment recommendations are heterogeneous.